Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Population-based universal screening for Lynch syndrome: ready, set... How?

Ngeow J, Eng C.

J Clin Oncol. 2013 Jul 10;31(20):2527-9. doi: 10.1200/JCO.2013.50.4373. Epub 2013 Jun 3. No abstract available.

PMID:
23733783
2.

Population-based molecular screening for Lynch syndrome: implications for personalized medicine.

Ward RL, Hicks S, Hawkins NJ.

J Clin Oncol. 2013 Jul 10;31(20):2554-62. doi: 10.1200/JCO.2012.46.8454. Epub 2013 Jun 3. Erratum in: J Clin Oncol. 2013 Nov 10;31(32):4167.

PMID:
23733757
3.

Lynch syndrome in colorectal cancer patients.

Giráldez MD, Castellví-Bel S, Balaguer F, Gonzalo V, Ocaña T, Castells A.

Expert Rev Anticancer Ther. 2008 Apr;8(4):573-83. doi: 10.1586/14737140.8.4.573. Review.

PMID:
18402524
4.

Informed consent and immunohistochemistry screening for Lynch syndrome.

Williams JL, Williams MS.

Genet Med. 2011 Sep;13(9):848-9. doi: 10.1097/GIM.0b013e318228efc8. No abstract available.

PMID:
21885923
5.

A state-wide population-based program for detection of lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours.

Schofield L, Grieu F, Goldblatt J, Amanuel B, Iacopetta B.

Fam Cancer. 2012 Mar;11(1):1-6. doi: 10.1007/s10689-011-9494-2.

PMID:
22120844
6.

[Hereditary nonpolyposis colorectal carcinoma: state of the art].

Holinski-Feder E, Morak M.

Dtsch Med Wochenschr. 2008 Aug;133(33):1690-5. doi: 10.1055/s-0028-1082788. Review. German.

PMID:
18686212
7.

Re: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.

Macrae F, Harris M.

J Natl Cancer Inst. 2005 Jun 15;97(12):936-7; author reply 937-8. No abstract available.

PMID:
15956656
8.

Review article: The Lynch syndrome (hereditary nonpolyposis colorectal cancer).

Vasen HF.

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:113-26. doi: 10.1111/j.1365-2036.2007.03479.x. Review.

9.

Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome).

Lynch HT, Lynch JF, Lynch PM.

J Natl Cancer Inst. 2007 Feb 21;99(4):261-3. No abstract available.

PMID:
17312298
10.

Detecting Lynch syndrome by pathologists.

van Krieken JH, Kets CM, Ligtenberg MJ, Hoogerbrugge N.

Verh Dtsch Ges Pathol. 2007;91:104-11.

PMID:
18314603
11.

Molecular biology from bench-to-bedside - which colorectal cancer patients should be referred for genetic counselling and risk assessment.

Jensen LH, Dysager L, Lindebjerg J, Kølvrå S, Byriel L, Crüger DG.

Eur J Cancer. 2010 Jul;46(10):1823-8. doi: 10.1016/j.ejca.2010.03.016. Epub 2010 Apr 21.

PMID:
20417091
12.

A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome.

Perera S, Ramyar L, Mitri A, Pollett A, Gallinger S, Speevak MD, Aronson M, Bapat B.

J Hum Genet. 2010 Jan;55(1):37-41. doi: 10.1038/jhg.2009.119. Epub 2009 Nov 13.

PMID:
19911012
13.

Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome).

Ramsoekh D, Van Leerdam ME, Wagner A, Kuipers EJ.

Aliment Pharmacol Ther. 2007 Dec;26 Suppl 2:101-11. doi: 10.1111/j.1365-2036.2007.03492.x. Review.

14.

[Tumour examination to detect hereditary colorectal cancer].

Hoogerbrugge N, Hermens RP, Nagengast F, Overbeek L, van Krieken HJ, Ligtenberg M.

Ned Tijdschr Geneeskd. 2012;156(42):A4982. Review. Dutch.

PMID:
23075775
15.

Frequency and application of the hot spot BRAF gene mutation (p.V600E) in the diagnostic strategy for Hereditary Nonpolyposis Colorectal Cancer.

Kadiyska TK, Konstantinova DV, Atanasov VR, Kremensky IM, Mitev VI.

Cancer Detect Prev. 2007;31(3):254-6. Epub 2007 Jun 12.

PMID:
17566669
16.

Screening for Lynch syndrome: a no-brainer: BRAF V600E mutation-specific immunohistochemistry: caveat emptor.

Bellizzi AM.

Am J Clin Pathol. 2015 Mar;143(3):320-4. doi: 10.1309/AJCP3ZDD3LTHWCZK. No abstract available.

PMID:
25696788
17.

Informed consent to microsatellite instability and immunohistochemistry screening for Lynch syndrome.

Chubak B, Heald B, Sharp RR.

Genet Med. 2011 Apr;13(4):356-60. doi: 10.1097/GIM.0b013e31820aee09.

PMID:
21407081
18.

Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study.

Tranø G, Sjursen W, Wasmuth HH, Hofsli E, Vatten LJ.

Br J Cancer. 2010 Feb 2;102(3):482-8. doi: 10.1038/sj.bjc.6605509. Epub 2010 Jan 5.

19.

Lynch or not Lynch? Is that always a question?

Colas C, Coulet F, Svrcek M, Collura A, Fléjou JF, Duval A, Hamelin R.

Adv Cancer Res. 2012;113:121-66. doi: 10.1016/B978-0-12-394280-7.00004-X. Review.

PMID:
22429854
20.

Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.

Dove-Edwin I, de Jong AE, Adams J, Mesher D, Lipton L, Sasieni P, Vasen HF, Thomas HJ.

Gastroenterology. 2006 Jun;130(7):1995-2000.

PMID:
16762622

Supplemental Content

Support Center